annb0t
Top 20
For the quarter ended June 2024, ResMed (RMD) reported revenue of $1.22 billion, up 9% over the same period last year. EPS came in at $2.08, compared to $1.60 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.21 billion, representing a surprise of +0.73%. The company delivered an EPS surprise of +2.46%, with the consensus EPS estimate being $2.03.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Str...
>>> Read more: Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics
The reported revenue compares to the Zacks Consensus Estimate of $1.21 billion, representing a surprise of +0.73%. The company delivered an EPS surprise of +2.46%, with the consensus EPS estimate being $2.03.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Str...
>>> Read more: Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics
